CryoLife (CRY) to Acquire On-X for $130M Upfront
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Piper Jaffray Says CryoLife (CRY) CEO is Shaking Things Up - Reiterates Overweight
December 24, 2015 7:33 AM ESTPiper Jaffray reiterated an Overweight rating and $15.00 price target on CryoLife (NYSE: CRY). CEO, Pat Mackin, was brought in, in Piper Jaffray's opinion, to shake things up. In 2015, Mackin focused on the successful removal of the FDA warning letter, settled the BCR patent litigation, and upgraded the overall management team.... More
